Norway Biologics Manufacturing Market Size & Outlook
Related Markets
Norway biologics manufacturing market highlights
- The Norway biologics manufacturing market generated a revenue of USD 302.3 million in 2025 and is expected to reach USD 870.3 million by 2033.
- The Norway market is expected to grow at a CAGR of 13.8% from 2026 to 2033.
- In terms of segment, contract manufacturing was the largest revenue generating mode of manufacturing in 2025.
- Contract Manufacturing is the most lucrative mode of manufacturing segment registering the fastest growth during the forecast period.
Biologics manufacturing market data book summary
| Market revenue in 2025 | USD 302.3 million |
| Market revenue in 2033 | USD 870.3 million |
| Growth rate | 13.8% (CAGR from 2026 to 2033) |
| Largest segment | Contract manufacturing |
| Fastest growing segment | Contract Manufacturing |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Contract Manufacturing, In-house manufacturing |
| Key market players worldwide | Novartis AG, Pfizer Inc, Amgen Inc, Novo Nordisk A/S, AbbVie Inc, Johnson & Johnson, Bristol-Myers Squibb Co, Eli Lilly and Co, F. Hoffmann-La Roche Ltd., WuXi Biologics., FUJIFILM Holdings Corp, Boehringer Ingelheim, Lonza, Samsung BioLogics |
Other key industry trends
- In terms of revenue, Norway accounted for 0.8% of the global biologics manufacturing market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Europe, Germany biologics manufacturing market is projected to lead the regional market in terms of revenue in 2033.
- Germany is the fastest growing regional market in Europe and is projected to reach USD 10,646.4 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Biologics Manufacturing Market Scope
Biologics Manufacturing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| WuXi Biologics. | View profile | - | - | - |
| Lonza | View profile | - | - | - |
| Novartis AG | View profile | - | - | - |
| F. Hoffmann-La Roche Ltd. | View profile | - | - | - |
| Novo Nordisk A/S | View profile | - | - | - |
| Samsung BioLogics | View profile | 1001-5000 | Incheon, Inch'on-jikhalsi, South Korea, Asia | https://www.samsungbiologics.com/ |
| Eli Lilly and Co | View profile | 43000 | Lilly Corporate Center, Indianapolis, IN, United States, 46285 | https://www.lilly.com |
| Boehringer Ingelheim | View profile | 10001+ | Ingelheim Am Rhein, Rheinland-Pfalz, Germany, Europe | https://www.boehringer-ingelheim.com/ |
| Bristol-Myers Squibb Co | View profile | 34100 | Route 206 and Province Line Road, Princeton, New Jersey, NJ, United States, 08543 | https://www.bms.com |
| FUJIFILM Holdings Corp | View profile | 83784 | 7-3, Akasaka 9-chome, Minato-ku, Tokyo, Japan, 107-0052 | http://www.fujifilmholdings.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| AbbVie Inc | View profile | 50000 | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 | http://www.abbvieinvestor.com |
| Amgen Inc | View profile | 26700 | One Amgen Center Drive, Thousand Oaks, CA, United States, 91320-1799 | https://www.amgen.com |
| Johnson & Johnson | View profile | 134400 | One Johnson and Johnson Plaza, New Brunswick, NJ, United States, 08933 | https://www.jnj.com |
Norway biologics manufacturing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biologics manufacturing market will help companies and investors design strategic landscapes.
Contract manufacturing was the largest segment with a revenue share of 66.56% in 2025. Horizon Databook has segmented the Norway biologics manufacturing market based on contract manufacturing, in-house manufacturing covering the revenue growth of each sub-segment from 2021 to 2033.
Reasons to subscribe to Norway biologics manufacturing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Norway biologics manufacturing market databook
-
Our clientele includes a mix of biologics manufacturing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Norway biologics manufacturing market , including forecasts for subscribers. This country databook contains high-level insights into Norway biologics manufacturing market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Norway biologics manufacturing market size, by mode of manufacturing, 2021-2033 (US$M)
Norway Biologics Manufacturing Market Outlook Share, 2025 & 2033 (US$M)
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
